Evidence map›Paper›PMID 24993829›Full record

ArticleThe Journal of biological chemistry2014

Structural insights into the activation of the RhoA GTPase by the lymphoid blast crisis (Lbc) oncoprotein.

Marc Lenoir, Masae Sugawara, Jaswant Kaur, Linda J Ball, Michael Overduin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marc LenoirFrom the School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Masae SugawaraFrom the School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Jaswant KaurFrom the School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Linda J BallStructural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, United Kingdom, and The Leibniz Institute of Molecular Pharmacology, Campus Buch, 13125 Berlin, Germany.
Michael OverduinFrom the School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom, m.overduin@bham.ac.uk.
University of Birmingham · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C511513/1Biotechnology and Biological Sciences Research Council BB/E013198/1Biotechnology and Biological Sciences Research Council BB/H024697/1Biotechnology and Biological Sciences Research Council BBS/B/10714Cancer Research UKWellcome Trust
6 · The paper itself

Abstract

The small GTPase RhoA promotes deregulated signaling upon interaction with lymphoid blast crisis (Lbc), the oncogenic form of A-kinase anchoring protein 13 (AKAP13). The onco-Lbc protein is a hyperactive Rho-specific guanine nucleotide exchange factor (GEF), but its structural mechanism has not been reported despite its involvement in cardiac hypertrophy and cancer causation. The pleckstrin homology (PH) domain of Lbc is located at the C-terminal end of the protein and is shown here to specifically recognize activated RhoA rather than lipids. The isolated dbl homology (DH) domain can function as an independent activator with an enhanced activity. However, the DH domain normally does not act as a solitary Lbc interface with RhoA-GDP. Instead it is negatively controlled by the PH domain. In particular, the DH helical bundle is coupled to the structurally dependent PH domain through a helical linker, which reduces its activity. Together the two domains form a rigid scaffold in solution as evidenced by small angle x-ray scattering and (1)H,(13)C,(15)N-based NMR spectroscopy. The two domains assume a "chair" shape with its back possessing independent GEF activity and the PH domain providing a broad seat for RhoA-GTP docking rather than membrane recognition. This provides structural and dynamical insights into how DH and PH domains work together in solution to support regulated RhoA activity. Mutational analysis supports the bifunctional PH domain mediation of DH-RhoA interactions and explains why the tandem domain is required for controlled GEF signaling.

Indexed as

A Kinase Anchor ProteinsAmino Acid SequenceDNA, ComplementaryEnzyme ActivationHumansMinor Histocompatibility AntigensMolecular Sequence DataMutationNuclear Magnetic Resonance, BiomolecularProtein ConformationProto-Oncogene ProteinsrhoA GTP-Binding ProteinSequence Homology, Amino AcidAKAP13 protein, humanA Kinase Anchor ProteinsDNA, ComplementaryMinor Histocompatibility AntigensProto-Oncogene ProteinsrhoA GTP-Binding ProteinAKAPGTPaseGuanine Nucleotide Exchange Factor (GEF)LbcNuclear Magnetic ResonanceOncogeneProtein-Protein InteractionProtein StructureRas Homolog Gene Family, Member A (RhoA)Rho GTPases

Identifiers

PMID24993829
PMCPMC4156082
OpenAlexW2012585995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.